US Stock MarketDetailed Quotes

FBLG FibroBiologics

Watchlist
  • 1.140
  • +0.090+8.57%
Close Feb 26 16:00 ET
  • 1.130
  • -0.010-0.87%
Post 17:10 ET
42.34MMarket Cap-2.18P/E (TTM)

About FibroBiologics Company

FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm’s product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O’Heeron on April 8, 2021 and is headquartered in Houston, TX.

Company Profile

SymbolFBLG
Company NameFibroBiologics
Listing DateJan 31, 2024
Founded2021
CEOMr. Peter O’Heeron
MarketNASDAQ
Employees10
Fiscal Year Ends12-31
Address455 East Medical Center Boulevard,Suite 300
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77598
Phone1-281-671-5150

Company Executives

  • Name
  • Position
  • Salary
  • Peter O’Heeron
  • Chairperson of the Board and Chief Executive Officer
  • 4.29M
  • Dr. Hamid Khoja, PhD
  • Chief Scientific Officer
  • 1.31M
  • Robert E. Hoffman, C.P.A.
  • Director, Interim Chief Financial Officer and Principal Accounting Officer
  • 388.54K
  • Dr. Victoria Niklas, M.D.
  • Independent Director
  • 381.54K
  • Stacy Ann Coen, M.B.A.
  • Independent Director
  • 384.54K
  • Matthew Link
  • Independent Director
  • 379.54K
  • Richard C. Cilento, Jr,M.B.A.
  • Independent Director
  • 376.54K
  • Ruben A. Garcia
  • General Counsel
  • --

Trending Stocks

Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More